Clinical Trial Consultants

Research Made Simple

866-389-1839

We help pharmaceutical companies work directly with private practice physicians to do excellent clinical research in Houston. Core values of honesty, integrity and charity, coupled with an unparalleled work ethic have allowed us to help hundreds of patients, numerous sponsors, and a handful of physicians. We hope you will reach out to us and become one of these people.

Contact Us Today

Many companies send protocols to our physicians on a regular basis. We spend a lot of time filling out Confidentiality Agreements and reading through protocols and their summaries very carefully. We do this to ensure that when we accept a study, we will recruit well for it. We want to ensure that our patient populations and logistics will fit well with every trial we participate in. As a result, we turn down more trials than we accept, but we hit our recruitment goals regularly.

In comparison to all of my other sites, West Houston Area Clinical Trial Consultants’ staff were the best prepared for my visits, the most responsive, the most capable at performing the protocol, the most friendly and accessible. All coordinators are very responsive and accommodating to my requests. Overall I am extremely satisfied with their performance”
— Michael F. - study monitor for Heart Failure trial

Current Studies and Projects

Current Work

Now enrolling children with uncontrolled epileptic seizures in Tomball, TX.

Enrollment is complete! Thank you to all of our volunteers, physicians, the sponsor, and monitors for helping make this trial a great success!

2nd Annual Habitat Build in Houston

Check out our 2nd Habitat House under construction! 

Recent Trial Experience

Previous Work

Our sites enrolled a very large number of patients for Lantheus. Katy Cardiology enrolled 55 patients and became the global highest enrolling site! There were over 100 sites involved, so this was an amazing accomplishment.

We had 22 patients enrolled between 3 sites, which we consolidated to 2 sites after the first year. Most patients participated for over 3 years in this endpoint-driven trial. 

A 104 Week, Randomized, Double Blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy of Aliskiren on the Progression of Atherosclerosis in Patients With Coronary Artery Disease When Added to Optimal Background Therapy

With this long-term Atrial Fibrillation trial, 22 patients were enrolled at Katy Cardiology, most of whom remained in the trial for over 3 years to help Daaichi determine if Edoxaban was superior to Warfarin, among other things. 

Most patients participated for almost 3 years, taking the study medication daily. The trial was designed to test if the study drug was effective in preventing heart attacks and strokes in patients with known coronary disease after a previous cardiovascular event.